Innoviva, Inc. (INVA)
NASDAQ: INVA · Real-Time Price · USD
19.15
+0.06 (0.31%)
Nov 20, 2024, 4:00 PM EST - Market closed
Innoviva Revenue
Innoviva had revenue of $89.51M in the quarter ending September 30, 2024, with 33.08% growth. This brings the company's revenue in the last twelve months to $352.75M, up 21.46% year-over-year. In the year 2023, Innoviva had annual revenue of $310.46M, down -6.30%.
Revenue (ttm)
$352.75M
Revenue Growth
+21.46%
P/S Ratio
3.42
Revenue / Employee
$3,149,509
Employees
112
Market Cap
1.20B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 310.46M | -20.88M | -6.30% |
Dec 31, 2022 | 331.34M | -60.53M | -15.45% |
Dec 31, 2021 | 391.87M | 55.07M | 16.35% |
Dec 31, 2020 | 336.79M | 75.78M | 29.03% |
Dec 31, 2019 | 261.02M | 12.00K | 0.00% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Pediatrix Medical Group | 2.01B |
Indivior | 1.18B |
Progyny | 1.14B |
Tilray Brands | 812.04M |
CareDx | 312.78M |
Maravai LifeSciences Holdings | 276.92M |
Mesoblast | 5.90M |
INVA News
- 8 days ago - Innoviva to Participate in the UBS Global Healthcare Conference - Business Wire
- 14 days ago - Innoviva Reports Third Quarter 2024 Financial Results; Highlights Recent Company Progress - Business Wire
- 5 weeks ago - Innoviva Specialty Therapeutics to Present New Clinical Data From Its Development Pipeline and Broad Commercial Portfolio at IDWeek 2024 - Business Wire
- 2 months ago - Innoviva to Participate in Upcoming Investor Conferences - Business Wire
- 4 months ago - Innoviva Reports Second Quarter 2024 Financial Results; Highlights Recent Company Progress - Business Wire
- 5 months ago - Analyst Projects Strong Growth for GSK-Innoviva Partnered Respiratory Drugs - Benzinga
- 6 months ago - Innoviva to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference - Business Wire
- 7 months ago - Innoviva Reports First Quarter 2024 Financial Results; Highlights Recent Company Progress - Business Wire